SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-041126
Filing Date
2023-11-14
Accepted
2023-11-14 16:16:15
Documents
77
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 2027633
2 ex4-1.htm EX-4.1 71737
3 ex4-2.htm EX-4.2 74630
4 ex10-12.htm EX-10.12 20961
5 ex10-13.htm EX-10.13 60362
6 ex10-14.htm EX-10.14 9370
7 ex10-15.htm EX-10.15 111049
8 ex10-16.htm EX-10.16 27876
9 ex31.htm EX-31 35545
10 ex32.htm EX-32 9448
  Complete submission text file 0001493152-23-041126.txt   9497008

Data Files

Seq Description Document Type Size
11 XBRL SCHEMA FILE age-20230930.xsd EX-101.SCH 47470
12 XBRL CALCULATION FILE age-20230930_cal.xml EX-101.CAL 66851
13 XBRL DEFINITION FILE age-20230930_def.xml EX-101.DEF 255294
14 XBRL LABEL FILE age-20230930_lab.xml EX-101.LAB 363968
15 XBRL PRESENTATION FILE age-20230930_pre.xml EX-101.PRE 333137
71 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1808786
Mailing Address 1101 MARINA VILLAGE PARKWAY SUITE 201 ALAMEDA CA 94501
Business Address 1101 MARINA VILLAGE PARKWAY SUITE 201 ALAMEDA CA 94501 510-671-8370
AgeX Therapeutics, Inc. (Filer) CIK: 0001708599 (see all company filings)

IRS No.: 821436829 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38519 | Film No.: 231406510
SIC: 2834 Pharmaceutical Preparations